31
Oct
Product Range – Tinefcon • Lord’s Mark Biotech, the exclusive distribution marketing partner for Tinefcon in India. • To set up a task force of scientific communicators to build awareness about difficult-to- treat skin conditions like Psoriasis. • Has set a revenue target of Rs. 100 crores for Tinefcon by 2025. Mumbai (Maharashtra) [India], October 31: Lord’s Mark Biotech, a subsidiary of Lord’s Mark Industries and a leading Healthcare and wellness company has launched Tinefcon, a patented medicine for treating Psoriasis. Lord’s Mark Biotech has signed an exclusivity agreement with INVEX Health Pvt Ltd for patented product developed by Piramal…
